Company Overview and News

 
How to Turn Your Mom’s Savings Into $1 Billion? Ask This Guy - Bloomberg

4h bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
Clark airport O&M attracts interest

6h bworldonline
A CONTRACT to operate and maintain (O&M) for 25 years an expanded Clark International Airport — designed to decongest the premier gateway in Metro Manila — has attracted several groups that sent representatives to a pre-bid conference in Bonifacio Global City, Taguig City on Monday.

1
Sony invests in image sensors, acquires more of EMI Music

10h technology.inquirer.net
Sony Corp. President Kenichiro Yoshida speaks as characters from Peanuts are shown at a press conference at the company’s headquarters Tuesday, May 22, 2018, in Tokyo. (AP)

 
The lucky 56: Xiaomi IPO to make dozens of workers millionaires

16h scmp
The employees stake in the company may soon be worth US$1 billion to US$3 billion, depending on the stock sale. That works out to $36 million each at the midpoint

 
SNE Stock: Sony Corp (ADR) Is This Decade’s Underappreciated Turnaround | InvestorPlace

23h investorplace
Among the so-called recovery stories, Sony Corp (ADR) (NYSE:SNE) is one of the more intriguing, and frustrating. Last year, SNE stock turned in a massive performance, delivering 60% returns to long-embattled shareholders. This followed a fairly solid 15% haul in 2016.

 
Amazon helps Shenzhen entrepreneur turn mom’s money into a billion dollars

2018-05-21 japantimes.co.jp
HONG KONG – After Steven Yang left his coveted job at Google, he asked his mother whether he should take venture capital money to fund his business idea.

 
Amazon helps ex-Googler turn mom’s money into a billion dollars

2018-05-21 livemint
Hong Kong: After Steven Yang left his coveted job at Google, he asked his mother whether he should take venture-capital money to fund his business idea.

 
Amazon helps Shenzhen ex-Googler turn mom's money into a billion

2018-05-21 scmp
Entrepreneur combined his Google money with his mom’s, and with less than US$1 million in seed capital moved from California to Shenzhen to build his technology business

 
Applied Materials, barometer for chip industry, drops the most in 9 years on weak forecast

2018-05-18 cnbc
Shares of Applied Materials fell sharply Friday after the company lowered its current-quarter revenue and sales projections in its semiconductor business below Wall Street expectations.

 
Could Micron Technology, Inc. Almost Double to $100?

2018-05-18 investorplace
Looking for high growth and a dirt-cheap valuation? Plenty of companies fit the former or the latter, many don’t fit either and a rare few can claim both descriptions. Micron Technology, Inc. (NASDAQ:MU) is one of the latter. Despite this, however, MU stock hasn’t been as much of a no-brainer trade as some investors may think.

 
China approves Toshiba's sale of US$18 bln chip unit to Bain-led group

2018-05-18 scmp
The anti-monopoly review had been the last and biggest hurdle to a successful sale of Toshiba Memory

 
Asian markets muted on lower expectations for U.S.-China trade talks - MarketWatch

2018-05-18 marketwatch
Asian markets were muted in early trading Friday, as investors appeared to be readjusting their expectations about trade negotiations between the U.S. and China.

 
LG Corp says chairman unwell, to nominate his son to board

2018-05-18 thestar.com.my
SEOUL: South Korea’s LG Corp said its long-time chairman is unwell and that it plans to nominate his son to its board of directors in preparation for leadership succession.

 
UPDATE 1-Samsung BioLogics said JV partner Biogen to exercise option by late June

2018-05-17 reuters
SEOUL, May 18 (Reuters) - South Korean drugmaker Samsung BioLogics said on Friday joint venture partner Biogen would exercise its call option to increase its stake to 50 percent minus one share in Samsung Bioepis.

 
UPDATE 2-China approves Toshiba's sale of $18 bln chip unit to Bain consortium

2018-05-17 reuters
TOKYO (Reuters) - Toshiba Corp (6502.T) said on Thursday that China regulators have approved the $18 billion sale of its chip unit to a consortium led by U.S. private equity firm Bain Capital, marking the end to a year-long saga surrounding its most prized asset.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

23h - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

23h - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...